RxDoctor Payments Data

Caleb Thomas, DPM

Podiatrist · University Place, WANPI 1578182812

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,662 of the $2,729 with a category attached, or 60.9%. 17 manufacturers reported payments, led by Stryker at 33.0% of the total.

$2,729in general payments, 2019–2025

Across 53 payments — averaging $51.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$902
  • Paragon 28, Inc.$886
  • Smith+Nephew$216
  • Medtronic$189
  • Invictus Surgical Incorporated$160
  • Fusion Orthopedics USA, LLC$68
  • plus $310 from 11 others

What the payments were for

  • Travel & lodging$1,06739%
  • Food & beverage$1,66261%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Stryker5$902
Paragon 28, Inc.10$886
Smith+Nephew5$216
Medtronic14$189
Invictus Surgical Incorporated2$160
Fusion Orthopedics USA, LLC4$68
Treace Medical Concepts, Inc.3$64
Nevro Corp.1$52
Novus Surgical Consultants1$36
Globus Medical1$28
Organogenesis Inc.1$27
Fidia Pharma USA Inc.1$25
Mimedx Group, Inc.1$20
Orthofix Medical, Inc.1$19
Biowound Solutions, Inc.1$17
Paratek Pharmaceuticals, Inc.1$15
Reprise Biomedical, Inc.1$5

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,729 in reported general payments places this provider in the 70th percentile of 134 podiatrist providers in Washington.

See all podiatrist providers in Washington

Medicare billing

Part B allowed, 2024
$315,154
Medicare patients
601
Services billed
4,628

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciclopirox15$351
Ketoconazole14$285
Cephalexin27$276
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen26$182
Terbinafine Hcl12$155

Paid to pharmacies, not to this prescriber.

Other podiatrist in University Place

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →